Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Intelligent Bio Solutions Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 12 | 10 | −2 |
| Shares | 852.9K | 344.2K | −508.8K (−59.6%) |
| Value | $3.36M | $868.0K | −$2.49M (−74.2%) |
New holders (3)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 31,140 | $78.0K | 0.00% |
| UBS Group AG | 6,332 | $16.0K | 0.00% |
| Morgan Stanley | 300 | $1.00K | 0.00% |
Sold out (5)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Anson Funds Management LP | 571,401 | $2.25M |
| Virtu Financial LLC | 24,897 | $98.0K |
| Goldman Sachs Group Inc | 19,422 | $77.0K |
| Jane Street Group, LLC | 19,129 | $75.0K |
| Citadel Advisors LLC | 17,171 | $68.0K |